News

  • New cancer treatment may reawaken immune system

    10.19.2021

    By combining chemotherapy, tumor injury, and immunotherapy, researchers show that the immune system can be re-engaged to destroy tumors in mice. Read more.


  • Weighing cancer cells to personalize drug choices

    10.05.2021

    A new study shows a link between patient survival and changes in tumor cell mass after glioblastoma treatment. Read more.


  • Counting cells may shed light on how cancer spreads

    09.28.2021

    MIT engineers devised a way to count elusive circulating tumor cells in mice, allowing them to study the dynamics of metastasis. Read more.


  • Study: Global cancer risk from burning organic matter comes from unregulated chemicals

    09.22.2021

    The researchers hope scientists and regulators will consider a broader class of compounds in evaluating cancer risk due to PAH exposure. Read more.


  • Engineers grow pancreatic “organoids” that mimic the real thing

    09.13.2021

    Studying these organoids could help researchers develop and test new treatments for pancreatic cancer, one of the deadliest types of cancer. Read more.


  • The Furst Lab engineered microbes to detect and degrade dangerous pesticides

    09.21.2021

    ACS Publication: A Microbial Electrochemical Technology to Detect and Degrade Organophosphate Pesticides. Article can be read here.


  • Smarter regulation of global shipping emissions could improve air quality and health outcomes

    08.17.2021

    Study shows a need to identify domestic and international pollution sources in policy design. Read more.


  • Biological engineers find a new target for malaria drugs

    08.10.2021

    Blocking a key enzyme could kill parasites that have evolved resistance to existing drugs. Read more.


  • Gerald Wogan, former Center Director from 1978-1986, passes away at 91

    08.05.2021

    Pioneering scientist isolated, characterized, and established the mechanisms of many environmental toxins relevant to public health. Read more.


  • Faster tracking of treatment responses

    02.02.2021

    Biological sensors developed by MIT spinout Glympse Bio could help clinicians make decisions for individual patients. Read more.